Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Leukemia

Free Subscription Articles published in PLoS One Retrieve available abstracts of 226 articles: HTML format

Single Articles

January 2021
1. GANT VU, Junco JJ, Terrell M, Rashid R, et al
   Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
   PLoS One. 2021;16:e0244863.
   PubMed     Abstract available
   
   
   
2. MASHIMA K, Oh I, Fujiwara K, Izawa J, et al
   Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
   PLoS One. 2021;16:e0245232.
   PubMed     Abstract available
   
   
   
3. JU HY, Lee JW, Cho HW, Hyun JK, et al
   DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.
   PLoS One. 2021;16:e0245667.
   PubMed     Abstract available
   
   
   
4. SEITA A, Nakaoka H, Okura R, Wakamoto Y, et al
   Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug.
   PLoS One. 2021;16:e0236534.
   PubMed     Abstract available
   
   
   
5. JALAL SD
   The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
   PLoS One. 2021;16:e0247491.
   PubMed     Abstract available
   
   
   
6. MOSQUERA ORGUEIRA A, Peleteiro Raindo A, Cid Lopez M, Antelo Rodriguez B, et al
   Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
   PLoS One. 2021;16:e0247093.
   PubMed     Abstract available
   
   
   
7. GHOBADI MZ, Emamzadeh R, Mozhgani SH
   Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia/lymphoma; the battle between oncogenes and anti-oncogenes.
   PLoS One. 2021;16:e0247713.
   PubMed     Abstract available
   
   
   
8. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kumar NAN, et al
   Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
   PLoS One. 2021;16:e0247989.
   PubMed     Abstract available
   
   
   
9. CHANG Y, Guyatt GH, Teich T, Dawdy JL, et al
   Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
   PLoS One. 2021;16:e0249087.
   PubMed     Abstract available
   
   
   
10. ELENS I, Deprez S, Billiet T, Sleurs C, et al
    Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
    PLoS One. 2021;16:e0250228.
    PubMed     Abstract available
    
    
    
11. YOO KH, Kim HJ, Min YH, Hong DS, et al
    Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.
    PLoS One. 2021;16:e0251011.
    PubMed     Abstract available
    
    
    
12. YU W, Wang W, Yu X
    Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0253012.
    PubMed     Abstract available
    
    
    
13. MOHSENI M, Kucharski C, K C RB, Nasrullah M, et al
    Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
    PLoS One. 2021;16:e0251719.
    PubMed     Abstract available
    
    
    
14. KOVY P, Orfi Z, Bors A, Kozma A, et al
    Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
    PLoS One. 2021;16:e0253386.
    PubMed     Abstract available
    
    
    
15. KIM SK, Goughnour PC, Lee EJ, Kim MH, et al
    Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.
    PLoS One. 2021;16:e0246106.
    PubMed     Abstract available
    
    
    
16. PONVILAWAN B, Kungwankiattichai S, Charoenngam N, Owattanapanich W, et al
    Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253896.
    PubMed     Abstract available
    
    
    
17. CATHERINET C, Passaro D, Gachet S, Medyouf H, et al
    NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0254184.
    PubMed     Abstract available
    
    
    
18. KARAMI K, Akbari M, Moradi MT, Soleymani B, et al
    Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques.
    PLoS One. 2021;16:e0254976.
    PubMed     Abstract available
    
    
    January 2020
19. VALENZUELA-VAZQUEZ L, Nunez-Enriquez JC, Sanchez-Herrera J, Jimenez-Hernandez E, et al
    Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia.
    PLoS One. 2020;15:e0227314.
    PubMed     Abstract available
    
    
    
20. LEE CH, Chen PH, Lin C, Wang CY, et al
    A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia.
    PLoS One. 2020;15:e0226879.
    PubMed     Abstract available
    
    
    
21. DAMPMANN M, Gorgens A, Mollmann M, Murke F, et al
    CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo.
    PLoS One. 2020;15:e0228674.
    PubMed     Abstract available
    
    
    
22. ARONS E, Zhou H, Sokolsky M, Gorelik D, et al
    Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
    PLoS One. 2020;15:e0227586.
    PubMed     Abstract available
    
    
    
23. BAYKAL-KOSE S, Acikgoz E, Yavuz AS, Gonul Geyik O, et al
    Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells.
    PLoS One. 2020;15:e0229104.
    PubMed     Abstract available
    
    
    
24. MOE KK, Polat M, Borjigin L, Matsuura R, et al
    New evidence of bovine leukemia virus circulating in Myanmar cattle through epidemiological and molecular characterization.
    PLoS One. 2020;15:e0229126.
    PubMed     Abstract available
    
    
    
25. MICHELIS R, Tadmor T, Aviv A, Stemer G, et al
    Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway.
    PLoS One. 2020;15:e0230033.
    PubMed     Abstract available
    
    
    
26. COLLIVA C, Cellini M, Dalla Porta F, Ferrari M, et al
    Psychosocial assessment of families caring for a child with acute lymphoblastic leukemia, epilepsy or asthma: Psychosocial risk as network of interacting symptoms.
    PLoS One. 2020;15:e0230194.
    PubMed     Abstract available
    
    
    
27. MOGENSEN PR, Grell K, Schmiegelow K, Overgaard UM, et al
    Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231209.
    PubMed     Abstract available
    
    
    
28. AGUILERA-DIAZ A, Vazquez I, Ariceta B, Manu A, et al
    Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
    PLoS One. 2020;15:e0227986.
    PubMed     Abstract available
    
    
    
29. SOK P, Lupo PJ, Richard MA, Rabin KR, et al
    Utilization of archived neonatal dried blood spots for genome-wide genotyping.
    PLoS One. 2020;15:e0229352.
    PubMed     Abstract available
    
    
    
30. WANG M, Zhang C
    Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    PLoS One. 2020;15:e0232520.
    PubMed     Abstract available
    
    
    
31. DRIEHUIS E, Oosterom N, Heil SG, Muller IB, et al
    Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231588.
    PubMed     Abstract available
    
    
    
32. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available
    
    
    
33. KOZLOVA V, Ledererova A, Ladungova A, Peschelova H, et al
    CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells.
    PLoS One. 2020;15:e0229170.
    PubMed     Abstract available
    
    
    
34. ROBERTO G, Spini A, Bartolini C, Moscatelli V, et al
    Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.
    PLoS One. 2020;15:e0229973.
    PubMed     Abstract available
    
    
    
35. CUESTA LM, Liron JP, Nieto Farias MV, Dolcini GL, et al
    Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile.
    PLoS One. 2020;15:e0234939.
    PubMed     Abstract available
    
    
    
36. MAALAND AF, Saidi A, Torgue J, Heyerdahl H, et al
    Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003.
    PLoS One. 2020;15:e0230526.
    PubMed     Abstract available
    
    
    
37. SCHONHERZ AA, Bodker JS, Schmitz A, Brondum RF, et al
    Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact.
    PLoS One. 2020;15:e0229593.
    PubMed     Abstract available
    
    
    
38. RODRIGUES JCG, Souza TP, Pastana LF, Ribeiro Dos Santos AM, et al
    Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.
    PLoS One. 2020;15:e0231651.
    PubMed     Abstract available
    
    
    
39. 
    Correction: Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile.
    PLoS One. 2020;15:e0236912.
    PubMed     Abstract available
    
    
    
40. LI J, Ran Q, Xu B, Luo X, et al
    Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis.
    PLoS One. 2020;15:e0236124.
    PubMed     Abstract available
    
    
    
41. LAVAU CP, Aumann WK, Sze SK, Gupta V, et al
    The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
    PLoS One. 2020;15:e0232036.
    PubMed     Abstract available
    
    
    
42. PRIEST ND, Dauer LT, Hoel DG
    Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.
    PLoS One. 2020;15:e0232597.
    PubMed     Abstract available
    
    
    
43. YOO KH, Cho J, Han B, Kim SH, et al
    Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults.
    PLoS One. 2020;15:e0235503.
    PubMed     Abstract available
    
    
    
44. 
    Retraction: S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells.
    PLoS One. 2020;15:e0237489.
    PubMed    
    
    
    
45. DRIEHUIS E, Oosterom N, Heil SG, Muller IB, et al
    Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0237488.
    PubMed     Abstract available
    
    
    
46. BRIX N, Rosthoj S, Glerup M, Hasle H, et al
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.
    PLoS One. 2020;15:e0237530.
    PubMed     Abstract available
    
    
    
47. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available
    
    
    
48. GRAYSON JM, Perez MD, Blevins R, Coe BN, et al
    Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity.
    PLoS One. 2020;15:e0234778.
    PubMed     Abstract available
    
    
    
49. JOHANSSON KA, Okland JM, Skaftun EK, Bukhman G, et al
    Estimating Health Adjusted Age at Death (HAAD).
    PLoS One. 2020;15:e0235955.
    PubMed     Abstract available
    
    
    
50. BORIES P, Prade N, Lagarde S, Cabarrou B, et al
    Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
    PLoS One. 2020;15:e0238795.
    PubMed     Abstract available
    
    
    
51. DELARMELINA E, Buzelin MA, Souza BS, Souto FM, et al
    High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil.
    PLoS One. 2020;15:e0239745.
    PubMed     Abstract available
    
    
    
52. LEWIS TR, Smith J, Griffin K, Aguiar S, et al
    NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation.
    PLoS One. 2020;15:e0236839.
    PubMed     Abstract available
    
    
    
53. NAGEL S, Pommerenke C, Meyer C, MacLeod RAF, et al
    Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia.
    PLoS One. 2020;15:e0240120.
    PubMed     Abstract available
    
    
    
54. RATTANATHAMMETHEE T, Tuitemwong P, Thiennimitr P, Sarichai P, et al
    Gut microbiota profiles of treatment-naive adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
    PLoS One. 2020;15:e0236460.
    PubMed     Abstract available
    
    
    
55. LUO L, Kang H, Li X, Ness SA, et al
    Two-step mixed model approach to analyzing differential alternative RNA splicing.
    PLoS One. 2020;15:e0232646.
    PubMed     Abstract available
    
    
    
56. TURK S, Turk C, Akbar MW, Kucukkaraduman B, et al
    Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.
    PLoS One. 2020;15:e0242497.
    PubMed     Abstract available
    
    
    
57. SZAKACS Z, Hegyi PJ, Farkas N, Hegyi P, et al
    Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review.
    PLoS One. 2020;15:e0243045.
    PubMed     Abstract available
    
    
    
58. INHESTERN L, Peikert ML, Krauth KA, Escherich G, et al
    Parents' perception of their children's process of reintegration after childhood cancer treatment.
    PLoS One. 2020;15:e0239967.
    PubMed     Abstract available
    
    
    
59. ZHANG W, Kuang P, Liu T
    Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis.
    PLoS One. 2020;15:e0243657.
    PubMed     Abstract available
    
    
    
60. BURNS JE, Reyes Perez D, Li Y, Gomez Garcia W, et al
    Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic.
    PLoS One. 2020;15:e0243795.
    PubMed     Abstract available
    
    
    
61. SAHAJPAL NS, Mondal AK, Ananth S, Njau A, et al
    Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
    PLoS One. 2020;15:e0240976.
    PubMed     Abstract available
    
    
    
62. YUAN B, El Dana F, Ly S, Yan Y, et al
    Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-beta-p38-ALDH2 pathway.
    PLoS One. 2020;15:e0242809.
    PubMed     Abstract available
    
    
    January 2019
63. MICHELIS R, Tadmor T, Barhoum M, Shehadeh M, et al
    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.
    PLoS One. 2019;14:e0209024.
    PubMed     Abstract available
    
    
    
64. BALLO O, Tarazzit I, Stratmann J, Reinheimer C, et al
    Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.
    PLoS One. 2019;14:e0210991.
    PubMed     Abstract available
    
    
    
65. STEINER M, Schneider L, Yillah J, Gerlach K, et al
    FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    PLoS One. 2019;14:e0210515.
    PubMed     Abstract available
    
    
    
66. CASTILLO D, Galvez JM, Herrera LJ, Rojas F, et al
    Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level.
    PLoS One. 2019;14:e0212127.
    PubMed     Abstract available
    
    
    
67. MULU FENTIE A, Tadesse F, Engidawork E, Gebremedhin A, et al
    Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian's with chronic myeloid leukemia.
    PLoS One. 2019;14:e0213557.
    PubMed     Abstract available
    
    
    
68. KITAMURA H, Tabe Y, Ai T, Tsuchiya K, et al
    A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.
    PLoS One. 2019;14:e0207170.
    PubMed     Abstract available
    
    
    
69. PANDITA A, Ramadas P, Poudel A, Saad N, et al
    Differential expression of miRNAs in acute myeloid leukemia quantified by Nextgen sequencing of whole blood samples.
    PLoS One. 2019;14:e0213078.
    PubMed     Abstract available
    
    
    
70. SONG Y, Gyarmati P
    Bacterial translocation in acute lymphocytic leukemia.
    PLoS One. 2019;14:e0214526.
    PubMed     Abstract available
    
    
    
71. SANDNER AS, Weggel R, Mehraein Y, Schneider S, et al
    Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
    PLoS One. 2019;14:e0215453.
    PubMed     Abstract available
    
    
    
72. LO TH, Abadir E, Gasiorowski RE, Kabani K, et al
    Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
    PLoS One. 2019;14:e0216368.
    PubMed     Abstract available
    
    
    
73. GUO J, Han Y, Li Y, Reddick WE, et al
    Reduced brain microstructural asymmetry in patients with childhood leukemia treated with chemotherapy compared with healthy controls.
    PLoS One. 2019;14:e0216554.
    PubMed     Abstract available
    
    
    
74. JEPSEN LO, Friis LS, Hansen DG, Marcher CW, et al
    Living with outpatient management as spouse to intensively treated acute leukemia patients.
    PLoS One. 2019;14:e0216821.
    PubMed     Abstract available
    
    
    
75. FOSTER KL, Kern KD, Chambers TM, Lupo PJ, et al
    Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis.
    PLoS One. 2019;14:e0217932.
    PubMed     Abstract available
    
    
    
76. PETRYKEY K, Lippe S, Robaey P, Sultan S, et al
    Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
    PLoS One. 2019;14:e0217314.
    PubMed     Abstract available
    
    
    
77. WOO YM, Kim S, Park JH, Lee NY, et al
    Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.
    PLoS One. 2019;14:e0218968.
    PubMed     Abstract available
    
    
    
78. NARAYAN R, Olsson N, Wagar LE, Medeiros BC, et al
    Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.
    PLoS One. 2019;14:e0219547.
    PubMed     Abstract available
    
    
    
79. MEYER LK, Delgado-Martin C, Maude SL, Shannon KM, et al
    CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    PLoS One. 2019;14:e0220026.
    PubMed     Abstract available
    
    
    
80. TROJANI A, Pungolino E, Dal Molin A, Lodola M, et al
    Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.
    PLoS One. 2019;14:e0218444.
    PubMed     Abstract available
    
    
    
81. SONG DY, Kim JA, Jeong D, Yun J, et al
    Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.
    PLoS One. 2019;14:e0220177.
    PubMed     Abstract available
    
    
    
82. YOSHINARI GH JR, Fassoni AC, Mello LF, Rego EM, et al
    Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia.
    PLoS One. 2019;14:e0221011.
    PubMed     Abstract available
    
    
    
83. CALDERON-RODRIGUEZ SI, Sanabria-Salas MC, Umana-Perez A
    A comparative proteomic study of plasma in Colombian childhood acute lymphoblastic leukemia.
    PLoS One. 2019;14:e0221509.
    PubMed     Abstract available
    
    
    
84. SILVA-JUNIOR AL, Alves FS, Kerr MWA, Xabregas LA, et al
    Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths.
    PLoS One. 2019;14:e0221518.
    PubMed     Abstract available
    
    
    
85. UTUAMA O, Mukhtar F, Pham YT, Dabo B, et al
    Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
    PLoS One. 2019;14:e0220864.
    PubMed     Abstract available
    
    
    
86. CHAHAL KK, Li J, Kufareva I, Parle M, et al
    Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.
    PLoS One. 2019;14:e0214901.
    PubMed     Abstract available
    
    
    
87. TANASKOVIC O, Verga Falzacappa MV, Pelicci PG
    Human cord blood (hCB)-CD34+ humanized mice fail to reject human acute myeloid leukemia cells.
    PLoS One. 2019;14:e0217345.
    PubMed     Abstract available
    
    
    
88. OOSTEROM N, de Jonge R, Smith DEC, Pieters R, et al
    Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
    PLoS One. 2019;14:e0221591.
    PubMed     Abstract available
    
    
    
89. RASHIDI A, Zhu Z, Kaiser T, Manias DA, et al
    Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.
    PLoS One. 2019;14:e0223890.
    PubMed     Abstract available
    
    
    
90. MA W, Qin Y, Chapuy B, Lu C, et al
    LRRC33 is a novel binding and potential regulating protein of TGF-beta1 function in human acute myeloid leukemia cells.
    PLoS One. 2019;14:e0213482.
    PubMed     Abstract available
    
    
    
91. 
    Retraction: Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1.
    PLoS One. 2019;14:e0224304.
    PubMed    
    
    
    
92. BALAGOPAL V, Hantel A, Kadri S, Steinhardt G, et al
    Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.
    PLoS One. 2019;14:e0224097.
    PubMed     Abstract available
    
    
    
93. CALDEIRA D, Alves D, Costa J, Ferreira JJ, et al
    Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis.
    PLoS One. 2019;14:e0211228.
    PubMed     Abstract available
    
    
    
94. POULIOT GP, Degar J, Hinze L, Kochupurakkal B, et al
    Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.
    PLoS One. 2019;14:e0221288.
    PubMed     Abstract available
    
    
    
95. MENEGUETTI GP, Santos JHPM, Obreque KMT, Barbosa CMV, et al
    Novel site-specific PEGylated L-asparaginase.
    PLoS One. 2019;14:e0211951.
    PubMed     Abstract available
    
    
    
96. KIM B, Lee H, Jang J, Kim SJ, et al
    Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms.
    PLoS One. 2019;14:e0212228.
    PubMed     Abstract available
    
    
    
97. WANG M, Wen J, Guo Y, Shen Y, et al
    Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children.
    PLoS One. 2019;14:e0224652.
    PubMed     Abstract available
    
    
    
98. VASIGHIZAKER A, Sharma A, Dehzangi A
    A novel one-class classification approach to accurately predict disease-gene association in acute myeloid leukemia cancer.
    PLoS One. 2019;14:e0226115.
    PubMed     Abstract available
    
    
    
99. TIJCHON E, Yi G, Mandoli A, Smits JGA, et al
    The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model.
    PLoS One. 2019;14:e0226435.
    PubMed     Abstract available
    
    
    
100. KIM K, McMillin GA, Bernard PS, Tantravahi S, et al
     Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia.
     PLoS One. 2019;14:e0226552.
     PubMed     Abstract available
     
     
     
101. BEAUD H, Albert O, Robaire B, Rousseau MC, et al
     Sperm DNA integrity in adult survivors of paediatric leukemia and lymphoma: A pilot study on the impact of age and type of treatment.
     PLoS One. 2019;14:e0226262.
     PubMed     Abstract available
     
     
     
102. SPIESS B, Rinaldetti S, Naumann N, Galuschek N, et al
     Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials.
     PLoS One. 2019;14:e0214305.
     PubMed     Abstract available
     
     
     
103. VARANASI PR, Ogonek J, Luther S, Dammann E, et al
     Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.
     PLoS One. 2019;14:e0213739.
     PubMed     Abstract available
     
     
     
104. GONZALEZ-SOLIS JL
     Discrimination of different cancer types clustering Raman spectra by a super paramagnetic stochastic network approach.
     PLoS One. 2019;14:e0213621.
     PubMed     Abstract available
     
     
     
105. TOKSVANG LN, Schmidt MS, Arup S, Larsen RH, et al
     Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
     PLoS One. 2019;14:e0212157.
     PubMed     Abstract available
     
     
     
106. FATHI E, Farahzadi R, Valipour B, Sanaat Z, et al
     Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation.
     PLoS One. 2019;14:e0215678.
     PubMed     Abstract available
     
     
     
107. KALB DM, Adikari SH, Hong-Geller E, Werner JH, et al
     Single-cell correlations of mRNA and protein content in a human monocytic cell line after LPS stimulation.
     PLoS One. 2019;14:e0215602.
     PubMed     Abstract available
     
     
     
108. RUGGIERI M, Berini C, Ducasa N, Malkovsky M, et al
     Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective view.
     PLoS One. 2019;14:e0217560.
     PubMed     Abstract available
     
     
     
109. KAROL SE, Janke LJ, Panetta JC, Ramsey LB, et al
     Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.
     PLoS One. 2019;14:e0216328.
     PubMed     Abstract available
     
     
     
110. PENG L, Guo H, Ma P, Sun Y, et al
     HoxA9 binds and represses the Cebpa +8 kb enhancer.
     PLoS One. 2019;14:e0217604.
     PubMed     Abstract available
     
     
     
111. FRACCHIOLLA NS, Sciume M, Orofino N, Guidotti F, et al
     Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
     PLoS One. 2019;14:e0216715.
     PubMed     Abstract available
     
     
     
112. JOST F, Schalk E, Rinke K, Fischer T, et al
     Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia.
     PLoS One. 2019;14:e0204540.
     PubMed     Abstract available
     
     
     
113. WU F, Song T, Yao Y, Song Y, et al
     Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1.
     PLoS One. 2019;14:e0216203.
     PubMed     Abstract available
     
     
     
114. KYVSGAARD N, Mikkelsen TS, Thastum M, Christensen AE, et al
     Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
     PLoS One. 2019;14:e0219539.
     PubMed     Abstract available
     
     
     
115. SHETH M, Gerovitch A, Welsch R, Markuzon N, et al
     The Univariate Flagging Algorithm (UFA): An interpretable approach for predictive modeling.
     PLoS One. 2019;14:e0223161.
     PubMed     Abstract available
     
     
     
116. BALLO O, Stratmann J, Serve H, Steffen B, et al
     Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy.
     PLoS One. 2019;14:e0223013.
     PubMed     Abstract available
     
     
     
117. ZHANG Y, Gundelach J, Lindquist LD, Baker DJ, et al
     Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL.
     PLoS One. 2019;14:e0224172.
     PubMed     Abstract available
     
     
     
118. PATEL RK, Weir MC, Shen K, Snyder D, et al
     Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance.
     PLoS One. 2019;14:e0225887.
     PubMed     Abstract available
     
     
     
119. WUNDERLICH M, Manning N, Sexton C, Sabulski A, et al
     Improved chemotherapy modeling with RAG-based immune deficient mice.
     PLoS One. 2019;14:e0225532.
     PubMed     Abstract available
     
     
     
120. NAGEL S, Scherr M, MacLeod RAF, Pommerenke C, et al
     NKL homeobox gene activities in normal and malignant myeloid cells.
     PLoS One. 2019;14:e0226212.
     PubMed     Abstract available
     
     
     
121. ALI EA, Kalli M, Wan D, Nakamura R, et al
     Characterization of human FcepsilonRIalpha chain expression and gene copy number in humanized rat basophilic leukaemia (RBL) reporter cell lines.
     PLoS One. 2019;14:e0221034.
     PubMed     Abstract available
     
     
     January 2018
122. POHLEN M, Thoennissen NH, Braess J, Thudium J, et al
     Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
     PLoS One. 2018;13:e0190802.
     PubMed     Abstract available
     
     
     
123. ROUT ED, Burnett RC, Labadie JD, Yoshimoto JA, et al
     Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia.
     PLoS One. 2018;13:e0191205.
     PubMed     Abstract available
     
     
     
124. KOLDEHOFF M, Lindemann M, Ross SR, Elmaagacli AH, et al
     Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.
     PLoS One. 2018;13:e0191482.
     PubMed     Abstract available
     
     
     
125. GETZ KD, Miller TP, Seif AE, Li Y, et al
     Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia.
     PLoS One. 2018;13:e0192529.
     PubMed     Abstract available
     
     
     
126. OHATA Y, Tsuchiya M, Hirai H, Yamaguchi S, et al
     Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma.
     PLoS One. 2018;13:e0191865.
     PubMed     Abstract available
     
     
     
127. KOKHAEI P, Hojjat-Farsangi M, Mozaffari F, Moshfegh A, et al
     Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.
     PLoS One. 2018;13:e0192839.
     PubMed     Abstract available
     
     
     
128. LANGE A, Jaskula E, Lange J, Dworacki G, et al
     The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
     PLoS One. 2018;13:e0190525.
     PubMed     Abstract available
     
     
     
129. GRUNDY M, Seedhouse C, Jones T, Elmi L, et al
     Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.
     PLoS One. 2018;13:e0190682.
     PubMed     Abstract available
     
     
     
130. KLONOFF-COHEN H, Navarro A, Klonoff EA
     Late effects awareness website for pediatric survivors of acute lymphocytic leukemia.
     PLoS One. 2018;13:e0193141.
     PubMed     Abstract available
     
     
     
131. KULLING PM, Olson KC, Hamele CE, Toro MF, et al
     Dysregulation of the IFN-gamma-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
     PLoS One. 2018;13:e0193429.
     PubMed     Abstract available
     
     
     
132. DZNELADZE I, Woolley JF, Rossell C, Han Y, et al
     SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
     PLoS One. 2018;13:e0191510.
     PubMed     Abstract available
     
     
     
133. COULIBALY A, Haas A, Steinmann S, Jakobs A, et al
     The natural anti-tumor compound Celastrol targets a Myb-C/EBPbeta-p300 transcriptional module implicated in myeloid gene expression.
     PLoS One. 2018;13:e0190934.
     PubMed     Abstract available
     
     
     
134. GRZYWOCZ Z, Hoser G, Sabalinska S, Ladyzynski P, et al
     Response of human normal and leukemia cells to factors released by amnion fragments in vitro.
     PLoS One. 2018;13:e0195035.
     PubMed     Abstract available
     
     
     
135. CHANG H, Gao Q, Ding W, Qing X, et al
     Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
     PLoS One. 2018;13:e0194245.
     PubMed     Abstract available
     
     
     
136. PANAGOPOULOS I, Gorunova L, Jacobsen EM, Andersen K, et al
     RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia.
     PLoS One. 2018;13:e0196181.
     PubMed     Abstract available
     
     
     
137. SPIESS B, Naumann N, Galuschek N, Rinaldetti S, et al
     The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
     PLoS One. 2018;13:e0196326.
     PubMed     Abstract available
     
     
     
138. SCHRAW JM, Yiu TT, Lupo PJ, Tsavachidis S, et al
     Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia.
     PLoS One. 2018;13:e0197408.
     PubMed     Abstract available
     
     
     
139. KSIONDA O, Mues M, Wandler AM, Donker L, et al
     Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
     PLoS One. 2018;13:e0193849.
     PubMed     Abstract available
     
     
     
140. ALI SA, Malakar D, Kaushik JK, Mohanty AK, et al
     Recombinant purified buffalo leukemia inhibitory factor plays an inhibitory role in cell growth.
     PLoS One. 2018;13:e0198523.
     PubMed     Abstract available
     
     
     
141. LIEN MY, Chou CH, Lin CC, Bai LY, et al
     Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
     PLoS One. 2018;13:e0197851.
     PubMed     Abstract available
     
     
     
142. BLUME JD, D'Agostino McGowan L, Dupont WD, Greevy RA Jr, et al
     Second-generation p-values: Improved rigor, reproducibility, & transparency in statistical analyses.
     PLoS One. 2018;13:e0188299.
     PubMed     Abstract available
     
     
     
143. GARCIA-VIDAL C, Cardozo-Espinola C, Puerta-Alcalde P, Marco F, et al
     Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.
     PLoS One. 2018;13:e0199531.
     PubMed     Abstract available
     
     
     
144. ZHANG H, Song G, Song G, Li R, et al
     Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
     PLoS One. 2018;13:e0199689.
     PubMed     Abstract available
     
     
     
145. WU TH, Shi L, Adrian J, Shi M, et al
     NF90/ILF3 is a transcription factor that promotes proliferation over differentiation by hierarchical regulation in K562 erythroleukemia cells.
     PLoS One. 2018;13:e0193126.
     PubMed     Abstract available
     
     
     
146. TRAN AN, Taylan F, Zachariadis V, Ivanov Ofverholm I, et al
     High-resolution detection of chromosomal rearrangements in leukemias through mate pair whole genome sequencing.
     PLoS One. 2018;13:e0193928.
     PubMed     Abstract available
     
     
     
147. NORGAARD CH, Jakobsen LH, Gentles AJ, Dybkaer K, et al
     Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study.
     PLoS One. 2018;13:e0193249.
     PubMed     Abstract available
     
     
     
148. OOSTEROM N, Griffioen PH, den Hoed MAH, Pieters R, et al
     Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
     PLoS One. 2018;13:e0199574.
     PubMed     Abstract available
     
     
     
149. BENADIBA J, Ansari M, Krajinovic M, Vachon MF, et al
     Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.
     PLoS One. 2018;13:e0193862.
     PubMed     Abstract available
     
     
     
150. NOBRE AFS, Almeida DS, Ferreira LC, Ferreira DL, et al
     Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin.
     PLoS One. 2018;13:e0194184.
     PubMed     Abstract available
     
     
     
151. CHACHAJ A, Wisniewski J, Rybka J, Butrym A, et al
     Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
     PLoS One. 2018;13:e0197148.
     PubMed     Abstract available
     
     
     
152. NAGEL S, Meyer C, Kaufmann M, Zaborski M, et al
     Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
     PLoS One. 2018;13:e0197194.
     PubMed     Abstract available
     
     
     
153. CLARISSE D, Van Wesemael K, Tavernier J, Offner F, et al
     Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
     PLoS One. 2018;13:e0197000.
     PubMed     Abstract available
     
     
     
154. MOORE TC, Messer RJ, Hasenkrug KJ
     Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.
     PLoS One. 2018;13:e0195402.
     PubMed     Abstract available
     
     
     
155. GENTIL M, Hugues P, Desterke C, Telliam G, et al
     Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
     PLoS One. 2018;13:e0200923.
     PubMed     Abstract available
     
     
     
156. GRUNDY M, Jones T, Elmi L, Hall M, et al
     Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells.
     PLoS One. 2018;13:e0196805.
     PubMed     Abstract available
     
     
     
157. KREUGER AL, Middelburg RA, Beckers EAM, de Vooght KMK, et al
     The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data.
     PLoS One. 2018;13:e0200655.
     PubMed     Abstract available
     
     
     
158. BURNS W, Peloquin K, Rondeau E, Drouin S, et al
     Cancer-related effects on relationships, long-term psychological status and relationship satisfaction in couples whose child was treated for leukemia: A PETALE study.
     PLoS One. 2018;13:e0203435.
     PubMed     Abstract available
     
     
     
159. TSUCHIYA K, Tabe Y, Ai T, Ohkawa T, et al
     Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.
     PLoS One. 2018;13:e0202429.
     PubMed     Abstract available
     
     
     
160. JAKEL F, Worm O, Lange S, Mertelsmann R, et al
     A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia.
     PLoS One. 2018;13:e0204393.
     PubMed     Abstract available
     
     
     
161. IBANEZ M, Carbonell-Caballero J, Such E, Garcia-Alonso L, et al
     The modular network structure of the mutational landscape of Acute Myeloid Leukemia.
     PLoS One. 2018;13:e0202926.
     PubMed     Abstract available
     
     
     
162. HATTORI H, Ishikawa Y, Kawashima N, Akashi A, et al
     Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
     PLoS One. 2018;13:e0204850.
     PubMed     Abstract available
     
     
     
163. BRESIN A, Ragone G, Cristofoletti C, Arcelli D, et al
     T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
     PLoS One. 2018;13:e0204775.
     PubMed     Abstract available
     
     
     
164. CARON M, St-Onge P, Drouin S, Richer C, et al
     Very long intergenic non-coding RNA transcripts and expression profiles are associated to specific childhood acute lymphoblastic leukemia subtypes.
     PLoS One. 2018;13:e0207250.
     PubMed     Abstract available
     
     
     
165. KAGEYAMA Y, Miwa H, Arakawa R, Tawara I, et al
     Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML.
     PLoS One. 2018;13:e0209295.
     PubMed     Abstract available
     
     
     
166. SCHUBERT M, Hackl H, Gassner FJ, Greil R, et al
     Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
     PLoS One. 2018;13:e0208753.
     PubMed     Abstract available
     
     
     
167. KUZELOVA K, Brodska B, Schetelig J, Rollig C, et al
     Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
     PLoS One. 2018;13:e0204290.
     PubMed     Abstract available
     
     
     
168. NORGAARD CH, Sogaard NB, Biccler JL, Pilgaard L, et al
     Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
     PLoS One. 2018;13:e0208180.
     PubMed     Abstract available
     
     
     
169. KOBLISH H, Li YL, Shin N, Hall L, et al
     Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
     PLoS One. 2018;13:e0199108.
     PubMed     Abstract available
     
     
     
170. SCHEICH S, Koenig R, Wilke AC, Lindner S, et al
     Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival.
     PLoS One. 2018;13:e0201169.
     PubMed     Abstract available
     
     
     
171. NG KP, Manjeri A, Lee LM, Chan ZE, et al
     The arginase inhibitor Nomega-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
     PLoS One. 2018;13:e0205254.
     PubMed     Abstract available
     
     
     
172. PILLING LC, Atkins JL, Kuchel GA, Ferrucci L, et al
     Red cell distribution width and common disease onsets in 240,477 healthy volunteers followed for up to 9 years.
     PLoS One. 2018;13:e0203504.
     PubMed     Abstract available
     
     
     
173. KOBLIHOVA J, Srutova K, Krutska M, Klamova H, et al
     AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome.
     PLoS One. 2018;13:e0206620.
     PubMed     Abstract available
     
     
     
174. VILLANUEVA PJ, Martinez A, Baca ST, DeJesus RE, et al
     Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
     PLoS One. 2018;13:e0206467.
     PubMed     Abstract available
     
     
     January 2017
175. YANG L, Sun H, Cao Y, Xuan B, et al
     Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
     PLoS One. 2017;12:e0175005.
     PubMed     Abstract available
     
     
     
176. LAJOIE M, Drouin S, Caron M, St-Onge P, et al
     Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia.
     PLoS One. 2017;12:e0174124.
     PubMed     Abstract available
     
     
     
177. JABO B, Morgan JW, Martinez ME, Ghamsary M, et al
     Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
     PLoS One. 2017;12:e0174760.
     PubMed     Abstract available
     
     
     
178. KALLEMEIJN MJ, de Ridder D, Schilperoord-Vermeulen J, van der Klift MY, et al
     Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRgammadelta+ T cell large granular lymphocyte leukemia.
     PLoS One. 2017;12:e0175670.
     PubMed     Abstract available
     
     
     
179. TSUNAKA M, Shinki H, Koyama T
     Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
     PLoS One. 2017;12:e0175765.
     PubMed     Abstract available
     
     
     
180. YE X, Torabi M, Lix LM, Mahmud SM, et al
     Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
     PLoS One. 2017;12:e0175701.
     PubMed     Abstract available
     
     
     
181. NISHIMORI A, Konnai S, Okagawa T, Maekawa N, et al
     In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection.
     PLoS One. 2017;12:e0174916.
     PubMed     Abstract available
     
     
     
182. GUTIERREZ-CAMINO A, Martin-Guerrero I, Garcia de Andoin N, Sastre A, et al
     Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
     PLoS One. 2017;12:e0177421.
     PubMed     Abstract available
     
     
     
183. MONDEJAR R, Perez C, Onaindia A, Martinez N, et al
     Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
     PLoS One. 2017;12:e0177524.
     PubMed     Abstract available
     
     
     
184. KARATHEDATH S, Rajamani BM, Musheer Aalam SM, Abraham A, et al
     Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
     PLoS One. 2017;12:e0177227.
     PubMed     Abstract available
     
     
     
185. ALEXANDER PM, Caudell DL, Kucera GL, Pladna KM, et al
     The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
     PLoS One. 2017;12:e0179798.
     PubMed     Abstract available
     
     
     
186. BUEHRING GC, Shen H, Schwartz DA, Lawson JS, et al
     Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development.
     PLoS One. 2017;12:e0179367.
     PubMed     Abstract available
     
     
     
187. DOS SANTOS PC, Panero J, Stanganelli C, Palau Nagore V, et al
     Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.
     PLoS One. 2017;12:e0179883.
     PubMed     Abstract available
     
     
     
188. WINKLER MT, Bushey RT, Gottlin EB, Campa MJ, et al
     Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.
     PLoS One. 2017;12:e0179841.
     PubMed     Abstract available
     
     
     
189. GU R, Wei H, Wang Y, Lin D, et al
     The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia.
     PLoS One. 2017;12:e0180624.
     PubMed     Abstract available
     
     
     
190. WOYWOD C, Gruber FX, Engh RA, Fla T, et al
     Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.
     PLoS One. 2017;12:e0179700.
     PubMed     Abstract available
     
     
     
191. ALONSO-DOMINGUEZ JM, Casado LF, Anguita E, Gomez-Casares MT, et al
     PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.
     PLoS One. 2017;12:e0181366.
     PubMed     Abstract available
     
     
     
192. BANDYOPADHYAY S, Li J, Traer E, Tyner JW, et al
     Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.
     PLoS One. 2017;12:e0179558.
     PubMed     Abstract available
     
     
     
193. MCKENZIE LM, Allshouse WB, Byers TE, Bedrick EJ, et al
     Childhood hematologic cancer and residential proximity to oil and gas development.
     PLoS One. 2017;12:e0170423.
     PubMed     Abstract available
     
     
     
194. ARCHER NP, Perez-Andreu V, Stoltze U, Scheurer ME, et al
     Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility.
     PLoS One. 2017;12:e0180488.
     PubMed     Abstract available
     
     
     
195. MARCEL V, Catez F, Berger CM, Perrial E, et al
     Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.
     PLoS One. 2017;12:e0170160.
     PubMed     Abstract available
     
     
     
196. MITSUHASHI Y, Furusawa Y, Aradate T, Zhao QL, et al
     3-O-trans-p-coumaroyl-alphitolic acid, a triterpenoid from Zizyphus jujuba, leads to apoptotic cell death in human leukemia cells through reactive oxygen species production and activation of the unfolded protein response.
     PLoS One. 2017;12:e0183712.
     PubMed     Abstract available
     
     
     
197. SETHI MK, Thol F, Stadler M, Heuser M, et al
     VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation.
     PLoS One. 2017;12:e0168096.
     PubMed     Abstract available
     
     
     
198. ALSOUS M, Abu Farha R, Alefishat E, Al Omar S, et al
     Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia.
     PLoS One. 2017;12:e0183119.
     PubMed     Abstract available
     
     
     
199. BRODSKA B, Kracmarova M, Holoubek A, Kuzelova K, et al
     Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
     PLoS One. 2017;12:e0175175.
     PubMed     Abstract available
     
     
     
200. BANJAR H, Ranasinghe D, Brown F, Adelson D, et al
     Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
     PLoS One. 2017;12:e0168947.
     PubMed     Abstract available
     
     
     
201. LAVROV AV, Ustaeva OA, Adilgereeva EP, Smirnikhina SA, et al
     Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
     PLoS One. 2017;12:e0182901.
     PubMed     Abstract available
     
     
     
202. WANG Y, Yin Y, Lan X, Ye F, et al
     Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway.
     PLoS One. 2017;12:e0177608.
     PubMed     Abstract available
     
     
     
203. FUCHS H, Rossmann N, Schmid MB, Hoenig M, et al
     Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience.
     PLoS One. 2017;12:e0179974.
     PubMed     Abstract available
     
     
     
204. BELVISO S, Iuliano R, Amato R, Perrotti N, et al
     The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells.
     PLoS One. 2017;12:e0178174.
     PubMed     Abstract available
     
     
     
205. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
     Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
     PLoS One. 2017;12:e0181805.
     PubMed     Abstract available
     
     
     
206. FATEHCHAND K, Santhanam R, Shen B, Erickson EL, et al
     Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells.
     PLoS One. 2017;12:e0181729.
     PubMed     Abstract available
     
     
     
207. PRABHU KS, Siveen KS, Kuttikrishnan S, Iskandarani A, et al
     Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
     PLoS One. 2017;12:e0180895.
     PubMed     Abstract available
     
     
     
208. LEE CH, Lin JC, Ho CL, Sun M, et al
     Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
     PLoS One. 2017;12:e0180050.
     PubMed     Abstract available
     
     
     
209. GORDIIENKO I, Shlapatska L, Kholodniuk V, Sklyarenko L, et al
     The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
     PLoS One. 2017;12:e0185940.
     PubMed     Abstract available
     
     
     
210. LATHAM S, Hughes E, Budgen B, Mechinaud F, et al
     Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia.
     PLoS One. 2017;12:e0185556.
     PubMed     Abstract available
     
     
     
211. CHOI SH, Severson E, Pear WS, Liu XS, et al
     The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
     PLoS One. 2017;12:e0185762.
     PubMed     Abstract available
     
     
     
212. WONG SM, Liu FH, Lee YL, Huang HM, et al
     Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
     PLoS One. 2017;12:e0186531.
     PubMed     Abstract available
     
     
     
213. LEE YL, Chen CW, Liu FH, Huang YW, et al
     Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.
     PLoS One. 2017;12:e0186528.
     PubMed     Abstract available
     
     
     
214. BUTI M, Manzano ML, Morillas RM, Garcia-Retortillo M, et al
     Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
     PLoS One. 2017;12:e0184550.
     PubMed     Abstract available
     
     
     
215. WEIR MC, Hellwig S, Tan L, Liu Y, et al
     Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
     PLoS One. 2017;12:e0181178.
     PubMed     Abstract available
     
     
     
216. LI S, Jin X, Wu H, Wang Y, et al
     HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.
     PLoS One. 2017;12:e0180142.
     PubMed     Abstract available
     
     
     
217. TAVERNA L, Tremolada M, Bonichini S, Tosetto B, et al
     Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor.
     PLoS One. 2017;12:e0186787.
     PubMed     Abstract available
     
     
     
218. ZHANG P, Zhao X, Zhang W, He A, et al
     Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/beta-catenin signaling pathway.
     PLoS One. 2017;12:e0186868.
     PubMed     Abstract available
     
     
     
219. ASKMYR M, von Palffy S, Hansen N, Landberg N, et al
     Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.
     PLoS One. 2017;12:e0186035.
     PubMed     Abstract available
     
     
     
220. MEHANNA P, Gagne V, Lajoie M, Spinella JF, et al
     Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines.
     PLoS One. 2017;12:e0184365.
     PubMed     Abstract available
     
     
     
221. CHABER R, Gurgul A, Wrobel G, Haus O, et al
     Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).
     PLoS One. 2017;12:e0187422.
     PubMed     Abstract available
     
     
     
222. MIN H, Niu M, Zhang W, Yan J, et al
     Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
     PLoS One. 2017;12:e0187971.
     PubMed     Abstract available
     
     
     
223. DUCHARTRE Y, Bachl S, Kim HN, Gang EJ, et al
     Effects of CD49d-targeted antisense-oligonucleotide on alpha4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies.
     PLoS One. 2017;12:e0187684.
     PubMed     Abstract available
     
     
     
224. HAGE-SLEIMAN R, Bahmad H, Kobeissy H, Dakdouk Z, et al
     Genomic alterations during p53-dependent apoptosis induced by gamma-irradiation of Molt-4 leukemia cells.
     PLoS One. 2017;12:e0190221.
     PubMed     Abstract available
     
     
     
225. BASNETT J, Xie V, Cisterne A, Bradstock K, et al
     Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia.
     PLoS One. 2017;12:e0188042.
     PubMed     Abstract available
     
     
     
226. CARRETTA M, Brouwers-Vos AZ, Bosman M, Horton SJ, et al
     BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.
     PLoS One. 2017;12:e0189102.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: